Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 11512141

Fibrinogen-like protein 2 (FGL2) monoclonal antibodies and their use in cancer detection a

The Board of Regents of the University of Texas System · Granted Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11512312

Treatment of Fuchs' endothelial corneal dystrophy

The Board of Regents of the University of Texas System · Granted Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11510880

Compositions and methods for organ specific delivery of nucleic acids

The Board of Regents of the University of Texas System · Granted Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11505585

FcRn antagonists and methods of use

The Board of Regents of the University of Texas System · Granted Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11497740

Use of Jumonji C demethylase inhibitors for the treatment and prevention of chemotherapy r

The Board of Regents of the University of Texas System · Granted Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11498963

Anti-LILRB antibodies and their use in detecting and treating cancer

The Board of Regents of the University of Texas System · Granted Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11492604

Transposase polypeptides and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11491115

Nanoparticles containing extracellular matrix for drug delivery

The Board of Regents of the University of Texas System · Granted Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11492650

Production of seleno-biologics in genomically recoded organisms

The Board of Regents of the University of Texas System · Granted Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11492368

Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

The Board of Regents of the University of Texas System · Granted Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11491184

Liquids rich in noble gas and methods of their preparation and use

The Board of Regents of the University of Texas System · Granted Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11484545

Compounds and methods for treating neurological and cardiovascular conditions

The Board of Regents of the University of Texas System · Granted Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11478489

Selective accretion of cytoprotectant in radiation-sensitive tissues and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11479560

OX2R compounds

The Board of Regents of the University of Texas System · Granted Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11479774

Methods of treating cancer harboring hemizygous loss of TP53

The Board of Regents of the University of Texas System · Granted Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11478517

Live attenuated recombinant HMPV with mutations in PDZ motifs of M2-2 protein, vaccine con

The Board of Regents of the University of Texas System · Granted Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11471449

Use of pridopidine to improve cognitive function and for treating Alzheimer's disease

The Board of Regents of the University of Texas System · Granted Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11471509

Compositions and methods relating to myomaker-induced muscle cell fusion

The Board of Regents of the University of Texas System · Granted Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11472813

OX2R compounds

The Board of Regents of the University of Texas System · Granted Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11472888

Reelin antibodies for treatment of atherosclerosis

The Board of Regents of the University of Texas System · Granted Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11466017

Heterocyclic inhibitors of PTPN11

The Board of Regents of the University of Texas System · Granted Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11459564

Modulation of frataxin expression

The Board of Regents of the University of Texas System · Granted Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11459617

Targeted measure of transcriptional activity related to hormone receptors

The Board of Regents of the University of Texas System · Granted Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11452775

Detection of arginine methylation of EGFR for prediction of resistance to therapy

The Board of Regents of the University of Texas System · Granted Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)